These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3435146)

  • 21. Development of an immunodetection test for a botulinum-like neurotoxin produced by Clostridium sp. RKD.
    Dixit A; Alam SI; Dhaked RK; Singh L
    Indian J Med Res; 2006 Sep; 124(3):355-62. PubMed ID: 17085839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clostridium botulinum type D neurotoxin: purification and detection.
    De Jongh KS; Schwartzkoff CL; Howden ME
    Toxicon; 1989; 27(2):221-8. PubMed ID: 2655181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of Clostridium botulinum type E toxin purified by two different procedures.
    Yokosawa N; Tsuzuki K; Syuto B; Oguma K
    J Gen Microbiol; 1986 Jul; 132(7):1981-8. PubMed ID: 2432159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clostridium botulinum type D toxin: purification, molecular structure, and some immunological properties.
    Miyazaki S; Iwasaki M; Sakaguchi G
    Infect Immun; 1977 Aug; 17(2):395-401. PubMed ID: 892912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of Clostridium botulinum type B toxin by an endogenous enzyme.
    DasGupta BR
    J Bacteriol; 1971 Dec; 108(3):1051-7. PubMed ID: 4945183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular construction of Clostridium botulinum type F progenitor toxin.
    Ohishi I; Sakaguchi G
    Appl Microbiol; 1975 Apr; 29(4):444-7. PubMed ID: 235882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Affinity chromatography purification of type A botulinum neurotoxin from crystalline toxic complex.
    Moberg LJ; Sugiyama H
    Appl Environ Microbiol; 1978 May; 35(5):878-80. PubMed ID: 655704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of neutral sugars in purified type G botulinum progenitor toxin and the effects of some glycolytic enzymes on its molecular dissociation and oral toxicity.
    Nukina M; Miyata T; Sakaguchi S; Sakaguchi G
    FEMS Microbiol Lett; 1991 Apr; 63(2-3):159-64. PubMed ID: 1905654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral toxicities of Clostridium botulinum type C and D toxins of different molecular sizes.
    Ohishi I; Sakaguchi G
    Infect Immun; 1980 May; 28(2):303-9. PubMed ID: 7399665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Separation and characterization of heavy and light chains from Clostridium botulinum type C toxin and their reconstitution.
    Syuto B; Kubo S
    J Biol Chem; 1981 Apr; 256(8):3712-7. PubMed ID: 6783645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new scaleable method for the purification of botulinum neurotoxin type E.
    Gessler F
    J Biotechnol; 2005 Sep; 119(2):204-11. PubMed ID: 15885835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Purification of fully activated Clostridium botulinum serotype B toxin for treatment of patients with dystonia.
    Arimitsu H; Inoue K; Sakaguchi Y; Lee J; Fujinaga Y; Watanabe T; Ohyama T; Hirst R; Oguma K
    Infect Immun; 2003 Mar; 71(3):1599-603. PubMed ID: 12595486
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular composition of the 16S toxin produced by a Clostridium botulinum type D strain, 1873.
    Nakajima H; Inoue K; Ikeda T; Fujinaga Y; Sunagawa H; Takeshi K; Ohyama T; Watanabe T; Inoue K; Oguma K
    Microbiol Immunol; 1998; 42(9):599-605. PubMed ID: 9802560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Purification and amino acid composition of type A botulinum neurotoxin.
    DasGupta BR; Sathyamoorthy V
    Toxicon; 1984; 22(3):415-24. PubMed ID: 6382680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Extraction and concentration of Clostridium botulinum toxins from specimens (author's transl)].
    Sonnenschein B; Bisping W
    Zentralbl Bakteriol Orig A; 1976 Mar; 234(2):247-59. PubMed ID: 5836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PEG precipitation coupled with chromatography is a new and sufficient method for the purification of botulinum neurotoxin type B [corrected].
    Zhao Y; Kang L; Gao S; Gao X; Xin W; Wang J
    PLoS One; 2012; 7(6):e39670. PubMed ID: 22761863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. COMPARATIVE GEL FILTRATION OF TOXIN PRECURSOR AND TRYPSIN-ACTIVATED TOXIN OF CLOSTRIDIUM BOTULINUM TYPE E.
    SAKAGUCHI G; SAKAGUCHI S; IMAI N
    J Bacteriol; 1964 Feb; 87(2):401-7. PubMed ID: 14151063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toxoid of Clostridium botulinum type F: purification and immunogenicity studies.
    Hatheway CL
    Appl Environ Microbiol; 1976 Feb; 31(2):234-42. PubMed ID: 793522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Purification of type E botulinum neurotoxin by high-performance ion exchange chromatography.
    Schmidt JJ; Siegel LS
    Anal Biochem; 1986 Jul; 156(1):213-9. PubMed ID: 3740411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Partial purification of an osteolytic toxin from Pasteurella multocida.
    Chanter N; Rutter JM; Mackenzie A
    J Gen Microbiol; 1986 Apr; 132(4):1089-97. PubMed ID: 3760819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.